Prospective observational study on treatment strategy for pancreatic cancer focusing on the chemotherapy response
Not Applicable
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000042331
- Lead Sponsor
- Department of hepato-biliary-pancreatic surgery, Okayama University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
Not provided
Exclusion Criteria
1.Cases without consent for the participation in this study 2.Cases with pregnancy or possibility of pregnancy 3.Cases with pulmonary dysfunction(arterial PaO2<=70mmHg) 4.Cases with cardiac dysfunction(New York Heart Association classification>=Class 3) 5.Cases with liver dysfunction(Child Pugh C) 6.Cases with renal dysfunction(patients with hemodialysis) 7.Cases with active infection 8.History of neurologically or psychologically significant disease, and cases with complications 9.Patients with best supportive care(BSC) 10.Patients whom principal investigator judged inappropriate for subjects of the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method relationship between the transition of CA19-9 and clinical outcome
- Secondary Outcome Measures
Name Time Method Overall survival Progression free survival Recurrence free survival Histopathological response rate for chemotherapy Complications or adverse effects due to chemotherapy